Friday 23/11/2018 |
08:00 | Registration |
|
| Session Chair |
Dr Laurent PROVINS (UCB, Braine-l'Alleud, Belgium) |
08:50 | Opening |
Dr Laurent PROVINS (UCB, Braine-l'Alleud, Belgium) |
09:00 | PL01 - Kinase Inhibitors for Non-oncological Indications: Is there a Future ? |
Dr Doriano FABBRO (PIQUR THERAPEUTICS, arlesheim, Switzerland) |
09:50 | PL02 - Chemoinformatics-Driven View of Kinase Drug Discovery
(Lecture sponsored by ChemMedChem) |
Prof. Jürgen BAJORATH (UNIVERSITY OF BONN, Bonn, Germany) |
10:40 | Coffee break and Exhibition |
|
| Session Chair |
Prof. Johan WOUTERS (UNAMUR, Namur, Belgium) |
11:15 | OC01 - A Fast in Silico Fragment-Based Design Tool for the Discovery of Novel Kinase Inhibitors |
Prof. Pascal BONNET (UNIVERSITY OF ORLÉANS, Orléans, France) |
11:35 | PL03 - Fragment Based Drug Discovery of Selective Inhibitors of Fibroblast Growth Factor Receptors |
Dr Patrick ANGIBAUD (JANSSEN R&D, Val de Reuil, France) |
12:25 | Lunch, Exhibition and Poster session |
|
| Session Chair |
Prof. Raphaël FREDERICK (UCLOUVAIN, Brussels-Woluwe, Belgium) |
14:00 | PL04 - Discovery, Development and In Vivo Profiling of a Novel Class of Immunosuppressive PI4KIIIβ Lipid Kinase Inhibitors |
Dr James REUBERSON (UCB, Slough, United Kingdom) |
14:50 | OC02 - Discovery And Development Of Highly Potent And Selective FLT3 Kinase Inhibitors, A New Class of Peripheral Drugs for Treating Neuropathic Pain |
Dr Claire AMIABLE (BCI PHARMA, Montpellier, France) |
15:10 | OC03 - Imidazo[4,5-B]Pyridine Derivatives as Potent Tam Inhibitors: From Synthesis To Cellular Imaging |
Dr Sandrine PIGUEL (UNIVERSITY PARIS-SACLAY, Orsay, France) |
15:30 | Coffee break, Exhibition and Poster session |
|
| Session Chair |
Dr Lionel POCHET (UNAMUR, Namur, Belgium) |
16:05 | PL05 - CDK8 Inhibitors with Pre-Engineered Long Residence Time: From Design to Tumor Xenograft Models |
Dr Koen HEKKING (MERCACHEM-SYNCOM, Nijmegen, The Netherlands) |
16:45 | PL06 - PTEFb/CDK9 Inhibitor BAY 1251152 for the Treatment of Cancer |
Dr Ulrich LÜCKING (BAYER HEALTHCARE, Basel, Switzerland) |
17:35 | Closing Remarks |
Prof. Koen AUGUSTYNS (UNIVERSITY OF ANTWERP, Antwerp, Belgium) |